Selected research
Market Structure
Global Prothrombin Complex Concentrates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Prothrombin Complex Concentrates market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Prothrombin Complex Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Prothrombin Complex Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Prothrombin Complex Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Prothrombin Complex Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Prothrombin Complex Concentrates include Takeda, Grifols, Octapharma AG and CSL Behring GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Prothrombin Complex Concentrates market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Prothrombin Complex Concentrates and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Prothrombin Complex Concentrates sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prothrombin Complex Concentrates market size, projected growth trends, production technologies, key applications, and end-use industries.
Prothrombin Complex Concentrates Segment by Company
Takeda
Grifols
Octapharma AG
CSL Behring GmbH
Prothrombin Complex Concentrates Segment by Type
3F Prothrombin Complex Concentrates
4F Prothrombin Complex Concentrates
Prothrombin Complex Concentrates Segment by Application
Hospital Pharmacies
Retail Pharmacies
Compound Pharmacies
Prothrombin Complex Concentrates Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex Concentrates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex Concentrates and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex Concentrates.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Prothrombin Complex Concentrates market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prothrombin Complex Concentrates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prothrombin Complex Concentrates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Prothrombin Complex Concentrates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 3F Prothrombin Complex Concentrates
- 4F Prothrombin Complex Concentrates
Applications
- Hospital Pharmacies
- Retail Pharmacies
- Compound Pharmacies
Companies covered
- Takeda
- Grifols
- Octapharma AG
- CSL Behring GmbH
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Prothrombin Complex Concentrates Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Prothrombin Complex Concentrates Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Prothrombin Complex Concentrates Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Prothrombin Complex Concentrates Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Prothrombin Complex Concentrates Market Dynamics
- 2.1 Prothrombin Complex Concentrates Industry Trends
- 2.2 Prothrombin Complex Concentrates Industry Drivers
- 2.3 Prothrombin Complex Concentrates Industry Opportunities and Challenges
- 2.4 Prothrombin Complex Concentrates Industry Restraints
3 Prothrombin Complex Concentrates Market by Manufacturers
- 3.1 Global Prothrombin Complex Concentrates Revenue by Manufacturers (2021-2026)
- 3.2 Global Prothrombin Complex Concentrates Sales by Manufacturers (2021-2026)
- 3.3 Global Prothrombin Complex Concentrates Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Prothrombin Complex Concentrates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Prothrombin Complex Concentrates Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Prothrombin Complex Concentrates Manufacturers, Product Type & Application
- 3.7 Global Prothrombin Complex Concentrates Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Prothrombin Complex Concentrates Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Prothrombin Complex Concentrates Players Market Share by Revenue in 2025
- 3.8.3 2025 Prothrombin Complex Concentrates Tier 1, Tier 2, and Tier 3
4 Prothrombin Complex Concentrates Market by Type
- 4.1 Prothrombin Complex Concentrates Type Introduction
- 4.1.1 3F Prothrombin Complex Concentrates
- 4.1.2 4F Prothrombin Complex Concentrates
- 4.2 Global Prothrombin Complex Concentrates Sales by Type
- 4.2.1 Global Prothrombin Complex Concentrates Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Prothrombin Complex Concentrates Sales by Type (2021-2032)
- 4.2.3 Global Prothrombin Complex Concentrates Sales Market Share by Type (2021-2032)
- 4.3 Global Prothrombin Complex Concentrates Revenue by Type
- 4.3.1 Global Prothrombin Complex Concentrates Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Prothrombin Complex Concentrates Revenue by Type (2021-2032)
- 4.3.3 Global Prothrombin Complex Concentrates Revenue Market Share by Type (2021-2032)
5 Prothrombin Complex Concentrates Market by Application
- 5.1 Prothrombin Complex Concentrates Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Retail Pharmacies
- 5.1.3 Compound Pharmacies
- 5.2 Global Prothrombin Complex Concentrates Sales by Application
- 5.2.1 Global Prothrombin Complex Concentrates Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Prothrombin Complex Concentrates Sales by Application (2021-2032)
- 5.2.3 Global Prothrombin Complex Concentrates Sales Market Share by Application (2021-2032)
- 5.3 Global Prothrombin Complex Concentrates Revenue by Application
- 5.3.1 Global Prothrombin Complex Concentrates Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Prothrombin Complex Concentrates Revenue by Application (2021-2032)
- 5.3.3 Global Prothrombin Complex Concentrates Revenue Market Share by Application (2021-2032)
6 Global Prothrombin Complex Concentrates Sales by Region
- 6.1 Global Prothrombin Complex Concentrates Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Prothrombin Complex Concentrates Sales by Region (2021-2032)
- 6.2.1 Global Prothrombin Complex Concentrates Sales by Region (2021-2026)
- 6.2.2 Global Prothrombin Complex Concentrates Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Prothrombin Complex Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Prothrombin Complex Concentrates Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Prothrombin Complex Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Prothrombin Complex Concentrates Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Prothrombin Complex Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Prothrombin Complex Concentrates Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Prothrombin Complex Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Prothrombin Complex Concentrates Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Prothrombin Complex Concentrates Revenue by Region
- 7.1 Global Prothrombin Complex Concentrates Revenue by Region
- 7.1.1 Global Prothrombin Complex Concentrates Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Prothrombin Complex Concentrates Revenue by Region (2021-2026)
- 7.1.3 Global Prothrombin Complex Concentrates Revenue by Region (2027-2032)
- 7.1.4 Global Prothrombin Complex Concentrates Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Prothrombin Complex Concentrates Revenue (2021-2032)
- 7.2.2 North America Prothrombin Complex Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Prothrombin Complex Concentrates Revenue (2021-2032)
- 7.3.2 Europe Prothrombin Complex Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Prothrombin Complex Concentrates Revenue (2021-2032)
- 7.4.2 Asia-Pacific Prothrombin Complex Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Prothrombin Complex Concentrates Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Prothrombin Complex Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Takeda
- 8.1.1 Takeda Company Information
- 8.1.2 Takeda Business Overview
- 8.1.3 Takeda Prothrombin Complex Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Takeda Prothrombin Complex Concentrates Product Portfolio
- 8.1.5 Takeda Recent Developments
- 8.2 Grifols
- 8.2.1 Grifols Company Information
- 8.2.2 Grifols Business Overview
- 8.2.3 Grifols Prothrombin Complex Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Grifols Prothrombin Complex Concentrates Product Portfolio
- 8.2.5 Grifols Recent Developments
- 8.3 Octapharma AG
- 8.3.1 Octapharma AG Company Information
- 8.3.2 Octapharma AG Business Overview
- 8.3.3 Octapharma AG Prothrombin Complex Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Octapharma AG Prothrombin Complex Concentrates Product Portfolio
- 8.3.5 Octapharma AG Recent Developments
- 8.4 CSL Behring GmbH
- 8.4.1 CSL Behring GmbH Company Information
- 8.4.2 CSL Behring GmbH Business Overview
- 8.4.3 CSL Behring GmbH Prothrombin Complex Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 CSL Behring GmbH Prothrombin Complex Concentrates Product Portfolio
- 8.4.5 CSL Behring GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Prothrombin Complex Concentrates Value Chain Analysis
- 9.1.1 Prothrombin Complex Concentrates Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Prothrombin Complex Concentrates Production Mode & Process
- 9.2 Prothrombin Complex Concentrates Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Prothrombin Complex Concentrates Distributors
- 9.2.3 Prothrombin Complex Concentrates Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst